• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾活检对糖尿病肾病的新解读:综述文章

New interpretation of diabetic nephropathy or diabetic kidney disease from kidney biopsy: review article.

作者信息

Ubara Yoshifumi, Sawa Naoki, Yamanouchi Masayuki, Kono Kei, Ohashi Kenichi

机构信息

Nephrology Center, Toranomon Hospital, 2-2-2, Toranomon, Minato, Tokyo, Japan.

Department of Pathology, Toranomon Hospital, Minato, Tokyo, Japan.

出版信息

Clin Exp Nephrol. 2025 Mar 24. doi: 10.1007/s10157-025-02661-4.

DOI:10.1007/s10157-025-02661-4
PMID:40126730
Abstract

Many nephrologists considered that renal involvement in diabetes patients was seen as nodular glomerulosclerosis (i.e., Kimmelstiel-Wilson lesions). However, they diagnosed diabetic nephropathy or diabetic kidney disease (DKD) from clinical information on diabetes history, and reports of evaluation by kidney biopsy were scarce. Since the publication of the Tervaert classification of diabetic nephropathy in 2010, reports of kidney biopsy in these patients have increased. Analysis of biopsy specimens revealed not only the Tervaert classification (class I to IV) based on glomerular lesions, but also various other pathologies. Besides nodular lesions, findings included paratubular basement membrane insudative lesions (PTBMILs), polar vasculosis, and nephropathy associated with novel drugs (sodium-glucose transport protein 2 inhibitors and dipeptidyl peptidase-4 inhibitors). PTBMILs are unique to diabetic nephropathy. In patients with continuous hyperglycemia and excessive salt intake, elevated blood osmolality (calculated by serum Na × 2 + serum glucose/18 + serum urea nitrogen/2.8) leads to thirst and excessive drinking, which results in fluid overload and generalized edema. The increase in circulating blood volume is thought to induce PTBMILs because of the influx of serum components into the endothelium of glomerular vessels. This case series review presents diverse kidney biopsy findings in patients with diabetic nephropathy or diabetic kidney disease as well as the pathogenesis.

摘要

许多肾脏病学家认为,糖尿病患者的肾脏受累表现为结节性肾小球硬化(即Kimmelstiel-Wilson病变)。然而,他们根据糖尿病病史的临床信息诊断糖尿病肾病或糖尿病肾脏疾病(DKD),而肾脏活检评估报告却很稀少。自2010年Tervaert糖尿病肾病分类发表以来,这些患者的肾脏活检报告有所增加。对活检标本的分析不仅揭示了基于肾小球病变的Tervaert分类(I至IV级),还发现了各种其他病理情况。除了结节性病变外,还包括肾小管周围基底膜渗出性病变(PTBMILs)、极周血管病变以及与新型药物(钠-葡萄糖转运蛋白2抑制剂和二肽基肽酶-4抑制剂)相关的肾病。PTBMILs是糖尿病肾病所特有的。在持续高血糖和盐摄入过多的患者中,血液渗透压升高(通过血清钠×2 +血清葡萄糖/18 +血清尿素氮/2.8计算)会导致口渴和过度饮水,进而导致液体超负荷和全身性水肿。循环血容量增加被认为会因血清成分流入肾小球血管内皮而诱发PTBMILs。本病例系列综述展示了糖尿病肾病或糖尿病肾脏疾病患者多样的肾脏活检结果及其发病机制。

相似文献

1
New interpretation of diabetic nephropathy or diabetic kidney disease from kidney biopsy: review article.肾活检对糖尿病肾病的新解读:综述文章
Clin Exp Nephrol. 2025 Mar 24. doi: 10.1007/s10157-025-02661-4.
2
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.用于治疗糖尿病和慢性肾脏病患者的胰岛素及降糖药物。
Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.液体活检能否通过低深度全基因组测序检测肉瘤患者的循环肿瘤DNA?一项初步评估。
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
5
Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.回豆巴通过代谢组学对糖尿病肾病大鼠肝肾功 能的调节作用研究
J Ethnopharmacol. 2025 Jun 11;351:120136. doi: 10.1016/j.jep.2025.120136.
6
Protein restriction for diabetic kidney disease.限制蛋白质摄入治疗糖尿病肾病。
Cochrane Database Syst Rev. 2023 Jan 3;1(1):CD014906. doi: 10.1002/14651858.CD014906.pub2.
7
Altered dietary salt intake for preventing diabetic kidney disease and its progression.改变膳食盐摄入量以预防糖尿病肾病及其进展。
Cochrane Database Syst Rev. 2023 Jan 16;1(1):CD006763. doi: 10.1002/14651858.CD006763.pub3.
8
Comparative efficacy of novel antidiabetic drugs on cardiovascular and renal outcomes in patients with diabetic kidney disease: A systematic review and network meta-analysis.新型降糖药物治疗糖尿病肾病患者心血管和肾脏结局的疗效比较:系统评价和网络荟萃分析。
Diabetes Obes Metab. 2022 Aug;24(8):1448-1457. doi: 10.1111/dom.14702. Epub 2022 Jun 6.
9
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.糖尿病肾病的多学科管理:一项系统评价与荟萃分析
JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

引用本文的文献

1
What a Modern Physician Should Know About microRNAs in the Diagnosis and Treatment of Diabetic Kidney Disease.现代医生应了解的关于微小RNA在糖尿病肾病诊断和治疗中的知识
Int J Mol Sci. 2025 Jul 11;26(14):6662. doi: 10.3390/ijms26146662.

本文引用的文献

1
Dapagliflozin-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Followed by Acute Interstitial Nephritis (AIN).达格列净引起的伴有嗜酸性粒细胞增多和全身症状的药物反应(DRESS)继以急性间质性肾炎(AIN)。
Intern Med. 2024 Dec 1;63(23):3203-3208. doi: 10.2169/internalmedicine.3347-23. Epub 2024 Apr 2.
2
A case of bullous pemphigoid and renal disease after dipeptidyl peptidase 4 inhibitor administration.一例使用二肽基肽酶4抑制剂后发生大疱性类天疱疮和肾脏疾病的病例。
CEN Case Rep. 2024 Aug;13(4):264-270. doi: 10.1007/s13730-023-00835-1. Epub 2023 Dec 6.
3
Differential impact of glomerular and tubule-interstitial histological changes on kidney outcome between non-proteinuric and proteinuric diabetic nephropathy.
非蛋白尿型与蛋白尿型糖尿病肾病肾小球和肾小管间质组织学改变对肾脏结局的影响差异。
Clin Exp Nephrol. 2024 Apr;28(4):282-292. doi: 10.1007/s10157-023-02433-y. Epub 2023 Nov 29.
4
Dipeptidyl peptidase-4 inhibitor-related renal disease.二肽基肽酶-4 抑制剂相关肾脏疾病。
J Diabetes Complications. 2023 Oct;37(10):108590. doi: 10.1016/j.jdiacomp.2023.108590. Epub 2023 Sep 1.
5
Kidney Transplantation From a Diabetic Donor to a Nondiabetic Recipient: A Case Report.糖尿病供者向非糖尿病受者的肾脏移植:病例报告。
Transplant Proc. 2022 Dec;54(10):2748-2753. doi: 10.1016/j.transproceed.2022.09.024. Epub 2022 Nov 22.
6
Correction to: Kidney biopsy guidebook 2020 in Japan.《2020年日本肾脏活检指南》勘误
Clin Exp Nephrol. 2021 Oct;25(10):1161. doi: 10.1007/s10157-021-02120-w.
7
Trajectories of kidney function in diabetes: a clinicopathological update.糖尿病患者肾功能的轨迹:临床病理更新。
Nat Rev Nephrol. 2021 Nov;17(11):740-750. doi: 10.1038/s41581-021-00462-y. Epub 2021 Aug 6.
8
Development of osmotic vacuolization of proximal tubular epithelial cells following treatment with sodium-glucose transport protein 2 inhibitors in type II diabetes mellitus patients-3 case reports.2 型糖尿病患者应用钠-葡萄糖共转运蛋白 2 抑制剂后近端肾小管上皮细胞渗透性空泡化的发展:3 例报告。
CEN Case Rep. 2021 Nov;10(4):563-569. doi: 10.1007/s13730-021-00609-7. Epub 2021 May 22.
9
Kidney biopsy guidebook 2020 in Japan.《2020年日本肾脏活检指南手册》
Clin Exp Nephrol. 2021 Apr;25(4):325-364. doi: 10.1007/s10157-020-01986-6.
10
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.镜下血尿是经肾活检证实的糖尿病肾病患者发生终末期肾病的一个危险因素。
BMJ Open Diabetes Res Care. 2020 Nov;8(2). doi: 10.1136/bmjdrc-2020-001863.